Patients with rheumatoid arthritis show several metabolic abnormalities, including abnormal tryptophan metabolism (Bett, 1962a, b; Flinn, Price, Yess, and Brown, 1964) . This was postulated as due to a functional deficiency in vitamin B6 (Flinn and others, 1964) , and McKusick, Sherwin, Jones, and Hsu (1964) did in fact demonstrate low urinary B6 in patients with rheumatoid arthritis. An alternative hypothesis, that the abnormality of tryptophan metabolism was the result of increased tryptophan pyrrolase activity due to the induction of this enzyme by increased fibrinogen breakdown, has also been proposed (editorial comment, Arthritis and Rheumatism, 1966) .
The formation of taurine from cysteine in the body is another metabolic pathway which maydepend on vitamin B6 (Wiss and Weber, 1964) deficiency resulting in low urinary output of taurine. The main product from the metabolism of cysteine is sulphate and the relevant pathways, as established in the rat, are shown in Fig. 1 . The decarboxylation stages involve pyridoxal phosphate as co-enzyme and are said to be particularly sensitive to B6 deficiency (Wiss and Weber, 1964; S6rbo, 1965; and Berlow, 1967) .
It seemed of interest to examine the urinary taurine and sulphate levels in patients with rheumatoid arthritis in view of the possible deficiency of vitamin B6 in such patients.
Material and Methods Clinical
Patients were selected who had definite rheumatoid arthritis as defined by the criteria of the American Rheumatism Association (Ropes, Bennett, Cobb, Jacox and Jessar, 1959) . Two groups were studied: one from whom salicylates were withheld during the time of urine collection and for the previous 3 or 4 days, and a second who received aspirin in doses of 4 to 6 g. daily throughout the experiment. (Berlow, 1967) .
The control group consisted of members and relatives of the staff of the Rheumatic Diseases Unit.
Biochemical 24-hour specimens of urine were collected under toluene. Measurements were made immediately in most cases; where this was not possible the urines were stored in a refrigerator.
Total and inorganic sulphate were determined by the method of Bray, Humphris, Thorpe, White, and Wood (1952) ; the urine was diluted 1:5 in water before measurements were made.
Taurine was estimated by the method of Sorbo (1961) and creatinine by the method of Bonsnes and Taussky (1945) . where xl and x2 are the mean values of the estimations, n1L and n2 are the number of estimations in each group, and S is an estimate of the standard deviation based on both samples jointly.
Results From a preliminary experiment it had been anticipated that aspirin might influence the results. Salicylate and its metabolites were shown not to interfere with the measurement of sulphate or taurine and to cause only an insignificant increase in the measurement of creatinine. It was clear, therefore, that any differences observed between groups would be metabolic in origin.
Apart from disease and the taking of aspirin, another difference between the controls and patients was in the matter of diet. The patients were on a hospital diet whereas the control subjects' diet was unrestricted. To obviate any effects due to this, the taurine/total sulphate ratio was calculated. This ratio indicates the proportion of cysteine being directed to the two main products of cysteine metabolism-sulphate and taurine-and hence should eliminate any differences in results due to variable cysteine intake.
The results obtained are given in the Table, which shows that males excreted higher amounts of total and inorganic sulphate than females (similar results are quoted by Cockbum, 1961) . Males also excreted higher amounts of taurine than females. This difference was probably dietary since in control subjects the mean taurine/total sulphate ratio (0 07) was the same for males and females. This difference did, however, make it necessary to compare the sexes separately when assessing the meaning of any change in taurine or sulphate output.
Patients with rheumatoid arthritis who were not receiving aspirin excreted significantly more taurine than controls; the taurine/total sulphate ratio was also markedly increased. Creatinine output was significantly lower. The total and inorganic sulphate levels were not significantly different. There is therefore no obvious difference in the conjugated sulphate output. Any differences in carbohydrate sulphate turnover, which might be indicated by this figure, are probably masked by the greater amount of conjugated sulphate formed in detoxication processes.
The hypertaurinuria found in patients with rheumatoid arthritis is obviously reduced by aspirin. This can be seen from the Table, where the mean taurine output and also the mean taurine/total sulphate ratio was lower in patients receiving aspirin. Statistically the ratio was significantly lower only for females.
The effect of aspirin on taurine excretion was studied in six individual patients. These results are illustrated in Fig. 2 , which shows that administration of aspirin was followed by a decrease in excretion of taurine.
The taurine/total sulphate ratios were also lowered. The results from Patient 4, who also had amyloid disease, have not been used in compiling the Table. Discussion The increased urinary output of taurine in patients with rheumatoid arthritis does not support the suggestion that there is a deficiency of vitamin B, in this disease, although increased taurine synthesis might make less B, available for other metabolic pathways, e.g. tryptophan degradation.
Several possible explanations for hypertaurinuria may be given. Hurley and Williams (1955) Other possibilities exist, including decreased conversion of taurine to taurocholic acid, but it would seem that the most likely explanation for the hypertaurinuria in rheumatoid arthritis is cellular damage. Thus, hypertaurinuria is found in such conditions as advanced carcinoma, liver disease, muscular dystrophy, paroxysmal myoglobinuria, and as a result of tissue damage due to irradiation (S6rbo, 1965) . The high renal clearance of taurine has been given as the reason for its being the predominant amino acid excreted in tissue destruction (Soupart, 1962) . Overproduction of taurine through a primary metabolic abnormality cannot be ruled out.
The mode of action of aspirin in reducing the output of taurine is still unexplained. Aspirin may act as an inhibitor in the vitamin B6 dependent reactions or may interfere in some other way with the pathway of cysteine metabolism. Alternatively, the effect of aspirin may be associated with the antiinflammatory action of the drug. As yet there is insufficient evidence to establish any of these hypotheses and further investigation is obviously required.
Summary
(1) 24-hour taurine, total and inorganic sulphate, and creatinine output were measured in control subjects and in two groups of patients with rheuma-from cell destruction, although an overproduction of toid arthritis-those receiving no drugs and those taurine per se cannot be excluded. taking aspirin.
(2) There was a difference between the sexes in excretion of these metabolites.
(3) The output of taurine and the taurine/total sulphate ratios were significantly greater in patients with rheumatoid arthritis than in the control group.
(4) Patients taking aspirin had a lower output of taurine and lower taurine/total sulphate ratios than patients taking no drugs.
( 5) 
